Table 1.
FP7 Cooperation projects and network of excellence that were represented at the workshop
| Acronym | Project description | Website |
|---|---|---|
| ATLAS | Development of Laser-Based Technologies and Prototype Instruments for Genome-Wide Chromatin ImmunoPrecipitation Analyses | http://www.atlas-eu.com/ |
| BLUEPRINT | A BLUEPRINT of haematopoietic Epigenomes | http://www.blueprint-epigenome.eu/ |
| CANCERDIP | The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management | http://www.cancerdip.eu/ |
| CELLOMATIC | High Throughput Systematic Single Cell Genomics using Micro/Nano-Fluidic Chips for Extracting, Pre-analysing, Selecting and Preparing Sequence-ready DNA | http://www.cellomatic.eu/ |
| CURELUNG | Epigenetic therapeutic strategies for improving lung cancer diagnosis | http://www.curelung.eu/ |
| ELIXIR | European Life-Science Infrastructure | http://www.elixir-europe.org/about |
| EPIFEMCARE | Epigenetics for Female Personalised Cancer Care | http://www.epifemcare.eu/ |
| EPIGENESYS | Epigenetics towards systems biology | http://www.epigenesys.eu/ |
| ESGI | European Sequencing and Genotyping Infrastructure | http://www.esgi-infrastructure.eu/ |
| EUROBATS | Identifying biomarkers of ageing using whole transcriptome sequencing | http://www.eurobats.eu/ |
| GENCODYS | Genetic and Epigenetic Networks in Cognitive Dysfunction | http://www.gencodys.eu/index.php |
| GENICA | Genomic instability in cancer and pre-cancer | http://genica.unige.ch/ |
| GEUVADIS | Genetic European Variation in Disease | http://www.geuvadis.org/ |
| IDEAL | Integrated research on developmental determinants of Aging and Longevity | http://www.ideal-ageing.eu/ |
| MARK-AGE | European study to establish biomarkers for human aging | http://www.mark-age.eu/ |
| MEDALL | Mechanisms of the Development of ALLergy | http://medall-fp7.eu/ |
| MODHEP | An integrative genomic-epigenomic approach to liver cancer | http://www.modhep.eu/ |
| NGS-PTL | Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia | http://www.ngs-ptl.com/ |
| RADIANT | Rapid development and distribution of statistical tools for high-throughput sequencing data | http://www.radiant-project.eu/ |
| READNA | REvolutionary Approaches and Devices for Nucleic Acid Analysis | http://www.cng.fr/READNA/ |
| SETTREND | Schistosoma epigenetics: targets, regulation, new drugs | http://settrend.cebio.org/ |
| SIROCCO | Silencing RNAs: organisers and coordinators of complexity in eukaryotic organisms | http://www.sirocco-project.eu/ |
| SWITCHBOX | Homeostatic mechanisms to facilitate maintenance of health from early life through to aging | http://www.switchbox-online.eu/ |
| International consortia | ||
| IHEC | International Human Epigenome Consortium | http://www.ihec-epigenomes.org/ |
| Cost actions | ||
| TD0905 Epigenetics from bench to bedside | http://www.cost.eu/domains_actions/cmst/Actions/TD0905 | |
| COST- FA1201– Epigenetics and periconception environment | http://www.cost.eu/domains_actions/fa/Actions/FA1201 | |
| COST-BM– 1201 Developmental origins of chronic lung diseases | http://www.cost.eu/domains_actions/bmbs/Actions/BM1201 | |
| COST- BM1102 Ciliates as model systems to study genome evolution, mechanisms of non-Mendelian inheritance, and their roles in environmental adaptation | http://www.cost.eu/domains_actions/bmbs/Actions/BM1102 | |
| COST Action BM1106 ‘The Genes in Irritable Bowel Syndrome Research Network Europe (GENIEUR)’ | http://www.cost.eu/domains_actions/bmbs/Actions/BM1106 | |
| COST-BM1007 – Mast cells and basophils – targets for innovative therapies | http://www.cost.eu/domains_actions/bmbs/Actions/BM1007 | |
| BM1006 Next Generation Sequencing Data Analysis network (SeqAhead) | http://www.cost.eu/domains_actions/bmbs/Actions/BM1006 | |
| BM0806 - Recent advances in histamine receptor H4R research | http://www.cost.eu/domains_actions/bmbs/Actions/BM0806 | |
| BM0801 Translating Genomic and epigenetic Studies of MDS and AML (EUGESMA) | http://www.cost.eu/domains_actions/bmbs/Actions/BM0801 |